17 research outputs found
LEFT VENTRICULAR HYPERTROPHY VERSUS ARTERIAL STIFFNESS AS PREDICTORS OF CORONARY ARTERY DISEASE IN ESSENTIAL HYPERTENSION: DATA FROM A GREEK 6-YEAR FOLLOW-UP STUDY
FAVORABLE EFFECTS OF IVABRADINE ON SYMPATHETIC OVERDRIVE AND ARTERIAL STIFFENING IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
FAVORABLE EFFECTS OF IVABRADINE ON SYMPATHETIC OVERDRIVE AND ARTERIAL STIFFENING IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
LEFT VENTRICULAR HYPERTROPHY VERSUS ARTERIAL STIFFNESS AS PREDICTORS OF CORONARY ARTERY DISEASE IN ESSENTIAL HYPERTENSION: DATA FROM A GREEK 6-YEAR FOLLOW-UP STUDY
RENAL RESISTIVE INDEX IS RELATED TO CARDIAC AND AORTIC HAEMODYNAMICS IN THE EARLY STAGES OF ESSENTIAL HYPERTENSION
WAIST CIRCUMFERENCE VERSUS OTHER OBESITY INDICES FOR PREDICTION OF CORONARY ARTERY DISEASE IN ESSENTIAL HYPERTENSION
WAIST CIRCUMFERENCE VERSUS OTHER OBESITY INDICES FOR PREDICTION OF CORONARY ARTERY DISEASE IN ESSENTIAL HYPERTENSION
The role of late gadolinium enhancement in predicting arrhythmic events in cardiac sarcoidosis patients – a mini-review
Sarcoidosis is a multisystem inflammatory disorder with an unknown origin. Symptomatic cardiac involvement is rare and occurs in about 5% of patients with sarcoidosis. Fatal ventricular arrhythmias are the most severe clinical presentation of the disease. Cardiac magnetic resonance (CMR) is a useful non-invasive tool for the risk stratification of ventricular arrhythmias and sudden cardiac death (SCD) in patients with cardiac sarcoidosis (CS). More specifically, late gadolinium enhancement (LGE), a CMR tool for scar detection, has been found to be significantly associated with arrhythmic events in CS patients. This review aims to present the existing evidence regarding the association of LGE with adverse events and especially with fatal ventricular arrhythmias